NYSBA Program: Policy, Pricing, and Market Strategy

May 8

On May 15, 2026, at 12:00 PM ET, I will be speaking as part of the New York State Bar Association Food, Drug & Cosmetic Law Section program, “Policy, Pricing, and Market Strategy.”

Healthcare organizations are increasingly operating in an environment where policy decisions directly influence pricing strategy, reimbursement planning, commercialization, and long term market positioning. Drug pricing reform, trade pressures, supply chain risk, and evolving regulatory frameworks are no longer isolated legal issues. They are becoming central business considerations across the healthcare and life sciences industries.

I look forward to joining the discussion with colleagues from across the healthcare and legal sectors.

Healthcare Policy, Drug Pricing, Healthcare Law, FDA, Life Sciences, Market Access, PBM Reform, Healthcare Strategy, Pharmaceutical Policy, Biopharma, Regulatory Strategy, Healthcare Regulation, Trade Policy

Ron Lanton

NYSBA Program: Policy, Pricing, and Market Strategy

When AI Starts Practicing Medicine Without a License